Massimiliano Mazza, PhD, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST), Meldola, Italy, describes the CAR-T project being run by the ‘Alleanza Contro il Cancro’ oncological network in Italy. Dr Mazza explains that this government-funded pre-clinical project aims to develop efficacious and affordable treatments for both solid tumors and hematological malignancies. This interview took place at the 4th Society of Hematologic Oncology (SOHO) Italy Annual Conference, held in Rome, Italy.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.